ABC
RYTM icon

Associated Banc-Corp’s Rhythm Pharmaceuticals RYTM Stock Holding History

Associated Banc-Corp’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-33
Closed -$1K – 1021
2020
Q3 		$1K Buy
+33
New +$757 ﹤0.01% 924

Other funds holding RYTM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Associated Banc-Corp's RYTM Position: Q4 2020 in Review

Associated Banc-Corp sold out of Rhythm Pharmaceuticals (RYTM) in Q4 2020, closing a stake of 33 shares — an estimated $1K sold.

Associated Banc-Corp first reported a position in RYTM in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 119 funds tracked by Wall St. Rank hold RYTM as of Q4 2020.

  • Associated Banc-Corp reported no remaining Rhythm Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Associated Banc-Corp sold 33 Rhythm Pharmaceuticals shares in Q4 2020, an estimated $1K.
  • Associated Banc-Corp first reported a position in Rhythm Pharmaceuticals in Q3 2020 and held it in 1 quarter.
  • Associated Banc-Corp's Rhythm Pharmaceuticals position peaked at $1K in Q3 2020.
  • 119 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q4 2020.

Based on Associated Banc-Corp's 13F filing for Q4 2020, filed 11 Feb 2021.